肥厚型心肌病的临床病程与管理 - Suppr

Suppr

超能文献

Clinical Course and Management of Hypertrophic Cardiomyopathy.

作者信息

Maron Barry J

机构信息

From the Hypertrophic Cardiomyopathy Center and Research Institute, Tufts Medical Center, Boston.

出版信息

N Engl J Med. 2018 Aug 16;379(7):655-668. doi: 10.1056/NEJMra1710575.

DOI:10.1056/NEJMra1710575

PMID:30110588

Abstract

摘要

相似文献

Clinical Course and Management of Hypertrophic Cardiomyopathy.

N Engl J Med. 2018 Aug 16;379(7):655-668. doi: 10.1056/NEJMra1710575.

The management of hypertrophic cardiomyopathy.

N Engl J Med. 1997 Mar 13;336(11):775-85. doi: 10.1056/NEJM199703133361107.

Myocardial disease: The patient with hypertrophic cardiomyopathy.

Heart. 2010 Nov;96(21):1764-72. doi: 10.1136/hrt.2009.190124.

Advances in understanding hypertrophic cardiomyopathy.

Hosp Pract (1995). 2001 May 15;36(5):23-5, 29-30, 33-6. doi: 10.3810/hp.2001.05.236.

Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.

J Cardiovasc Med (Hagerstown). 2006 Sep;7(9):711-3. doi: 10.2459/01.JCM.0000243007.97793.0f.

Misconceptions and Facts About Hypertrophic Cardiomyopathy.

Am J Med. 2016 Feb;129(2):148-52. doi: 10.1016/j.amjmed.2015.07.035. Epub 2015 Aug 20.

The never ending story of risk stratification for sudden death in hypertrophic cardiomyopathy.

Am J Cardiol. 2011 Jun 15;107(12):1871. doi: 10.1016/j.amjcard.2011.02.357.

Results from the Kochi RYOMA Study. Atrial fibrillation is a major risk of morbidity in patients with hypertrophic cardiomyopathy.

Circ J. 2009 Sep;73(9):1589-90. doi: 10.1253/circj.cj-09-0433.

Arrhythmia and hypertrophic cardiomyopathy.

Arch Mal Coeur Vaiss. 1992 Dec;85 Spec No 4:31-6.

Sudden death in hypertrophic cardiomyopathy.

N Engl J Med. 2000 Feb 10;342(6):422-4. doi: 10.1056/NEJM200002103420609.

引用本文的文献

Prognostic value of preoperative NT-proBNP in patients with obstructive hypertrophic cardiomyopathy undergoing septal myectomy.

JTCVS Open. 2025 Jun 28;26:122-131. doi: 10.1016/j.xjon.2025.06.017. eCollection 2025 Aug.

Creating an atlas of variant effects to resolve variants of uncertain significance and guide cardiovascular medicine.

Nat Rev Cardiol. 2025 Sep 1. doi: 10.1038/s41569-025-01201-7.

Healthcare access, symptom burden, and psychological impact in hypertrophic cardiomyopathy: a multinational patient-driven survey.

Int J Cardiol Cardiovasc Risk Prev. 2025 Aug 4;27:200485. doi: 10.1016/j.ijcrp.2025.200485. eCollection 2025 Dec.

Early detection of right atrial dysfunction in patients with hypertrophic cardiomyopathy using cardiac magnetic resonance feature tracking.

Quant Imaging Med Surg. 2025 Aug 1;15(8):7210-7223. doi: 10.21037/qims-2024-2871. Epub 2025 Jul 30.

Prognostic Value of Coronary Angiography-Derived Index of Microvascular Resistance in Patients With Hypertrophic Cardiomyopathy.

MedComm (2020). 2025 Jul 25;6(8):e70289. doi: 10.1002/mco2.70289. eCollection 2025 Aug.

A Systematic Review of Clinical Trials on Mavacamten in Hypertrophic Cardiomyopathy.

Heart Int. 2025 Jun 26;19(1):31-40. doi: 10.17925/HI.2025.19.1.7. eCollection 2025.

The associations among genetic features, late gadolinium enhancement and prognosis in hypertrophic cardiomyopathy.

Front Cardiovasc Med. 2025 Jul 7;12:1597405. doi: 10.3389/fcvm.2025.1597405. eCollection 2025.

Incidence and Healthcare Resource Utilization Among Patients with Hypertrophic Cardiomyopathy Hospitalized for Heart Failure in Japan.

Cardiol Ther. 2025 Jul 19. doi: 10.1007/s40119-025-00427-3.

Progressive Deterioration of the Right Ventricular Function in a Patient with Non-Obstructive HCM Complicated by Atrial Fibrillation: A Case Presentation.

Int Med Case Rep J. 2025 Jul 7;18:837-843. doi: 10.2147/IMCRJ.S529591. eCollection 2025.

Cardiac myosin inhibitors in hypertrophic cardiomyopathy.

J Cardiovasc Imaging. 2025 Jul 7;33(1):7. doi: 10.1186/s44348-025-00052-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验